preferred drug
Scope
Date
~
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
KKR invests $2 bn in SK E&S' new preferred shares
KKR & Co. has signed an agreement to buy 2.4 trillion won ($2 billion) worth of newly-issued preferred shares in SK E&S Co., the US private ...
Nov 05, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Edison-led consortium named preferred buyer of Ssangyong Motor
A consortium led by electric bus maker Edison Motors Co. has been named the preferred buyer of South Korea’s troubled sport utility vehicle ma...
Oct 20, 2021 (Gmt+09:00)
language -
Economy
S.Korean companies stockpile record-level dollar holdings
South Korean companies have built up their dollar holdings to record levels, following record-breaking shipment growth this year, as rising raw mate...
Oct 20, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
KKR named as preferred buyer of SK E&S' $2 bn new shares
KKR & Co. has secured the exclusive negotiating rights to buy SK E&S Co.'s new preferred shares worth 2.4 trillion won ($2 billion), which t...
Oct 12, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Capital raising
SK E&S' $2 bn preferred share deal shortlisted to four candidates
SK E&S Co., the largest city gas supplier in South Korea, has shortlisted four candidates among seven preliminary bidders to invest in 2 trillio...
Aug 13, 2021 (Gmt+09:00)
-
Capital raising
KKR, IMM PE in bid for SK E&S' $2 bn preferred shares
KKR & Co., IMM Private Equity and Glenwood Private Equity are among the preliminary bidders for 2 trillion won ($1.9 billion) worth of new prefe...
Aug 04, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language -
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Sale of Citibank Korea gains traction; preferred buyer may emerge in July
The sale of Citibank Korea’s consumer banking business is gaining traction as potential bidders have started due diligence of the bank, with e...
Jun 29, 2021 (Gmt+09:00)
-
Food & Beverage
Malaysia becomes preferred destination for Korea’s convenience chains
South Korea’s major convenience store chains are rushing to enter the Malaysian market. E-Mart 24, the convenience chain operated by Shinsegae...
Jun 24, 2021 (Gmt+09:00)
-
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
Drug development
SK injects $200 mn into Roivant partnership for new drug development
SK Holdings Co., the holding company of South Korean conglomerate SK Group, has become the first Korean company to foray into the targeted protein d...
Dec 07, 2020 (Gmt+09:00)
-
Korean investors' survey
Korean investors pick private debt as preferred asset class
South Korea’s institutional investors, including pension funds, mutual aid associations and insurers, plan to increase the private debt portion ...
Oct 27, 2020 (Gmt+09:00)
-
Real Estate
Hana Financial named preferred buyer of $700 mn Seattle office tower: report
A consortium of South Korea's Hana Alternative Asset Management Co. and other units of Hana Financial Group has signed a preliminary agreement to buy ...
Sep 18, 2020 (Gmt+09:00)
-
Alternative investments
Mirae Asset named preferred negotiator for 3 Amazon-leased logistics centers in US
Mirae Asset Global Investments Co. has been named the preferred negotiator to acquire three logistics centers in the US leased to American retail gian...
Sep 09, 2020 (Gmt+09:00)
-
Defense
Hanwha Defense named preferred supplier of howitzers to Australia
Hanwha Defense Co. has been named the preferred supplier of howitzers and associated support equipment to Australia, signaling the superiority of Sout...
Sep 03, 2020 (Gmt+09:00)
-
Bio
Celltrion to co-develop pill-type autoimmune disease drug with UK startup
Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...
Aug 20, 2020 (Gmt+09:00)
-
NH Investment named as preferred buyer of Seoul Square in $873 mn deal
NH Investment & Securities Co. Ltd. was chosen as the preferred buyer for a landmark Seoul office building, according to the South Korean brokerag...
Sep 13, 2018 (Gmt+09:00)
-
Hana Financial buys US REIT’s preferred stocks for $125 mn
Hana Financial Investment Co. Ltd. has bought new preferred shares issued by a US real estate investment trust company for $125 million, ahead of the ...
Aug 14, 2018 (Gmt+09:00)
-
Korean VC firms invest in UK drug developer, first after Brexit
Celleron Therapeutics Ltd., a cancer treatment developer founded by Oxford University professors, is poised to attract $26 million from South Korean a...
Oct 17, 2016 (Gmt+09:00)